Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Impact of Low vs High PEEP on Diaphragm and Lung Function in Mechanically Ventilated Patients

Official title: The Impact of Low Versus High Positive End-Expiratory Pressure on Diaphragm Function, Ventilation Efficiency, and Lung Mechanics During Pressure Support Ventilation: A Randomized Interventional Crossover Study

Run by Vastra Gotaland Region · NCT07188038 · Data updated 2026-11-12

This study tests whether different levels of PEEP (low, medium, high) change diaphragm effort and ventilation effectiveness in adults on pressure-support ventilation in the ICU.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorVastra Gotaland Region
Government
Locations2 sites (Gothenburg, Västra Götaland County and 1 other locations)
StatusRecruiting
StartedAugust 31, 2026
Main results expectedJuly 31, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 2, 2026
Trial IDNCT07188038 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) on mechanical ventilation with pressure support or anticipated transition to pressure support, with moderate oxygen needs and no prohibitive contraindications to esophageal catheterization.

Probably not a fit

Patients with circulatory instability, high norepinephrine dose, recent muscle relaxation, pregnancy, or conditions increasing pneumothorax risk may derive less or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will compare three PEEP levels (4, 10, and 16 cmH2O) in patients requiring mechanical ventilation with pressure support. Outcomes will include diaphragm activity and contractility, lung mechanics, and ventilator performance measured with esophageal manometry, diaphragm EMG, ultrasound, and ventilator data. The goal is to see if higher PEEP alters inspiratory effort, diaphragm function, or lung compliance during supported breathing. Safety monitoring includes predefined discontinuation criteria for instability or intolerance. The study is conducted in Swedish ICUs with central oversight by regional authorities and Sahlgrenska/Särelsen University Hospital collaborators.

Why it matters

Potential benefit: If successful, findings could guide PEEP settings to optimize diaphragm function and ventilation efficiency in mechanically ventilated patients.

How similar studies have gone: Prior studies have explored PEEP effects on lung mechanics, but this precise diaphragm- and ventilator-function comparison across three PEEP levels is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Mechanical ventilation with pressure support or mechanical ventilation with possibility to transition to pressure support
* Oxygen requirement ≤ 50%
* Pressure support ≤ 12 cmH2O
* PEEP ≤ 12 cmH2O
* Age ≥ 18 years
* Adequate intravascular volume status

Exclusion Criteria:

* Circulatory instability
* Brain death diagnosis/brain death evaluation
* Norepinephrine dose \> 0.4 µg/kg/min
* Muscle relaxation administered within 2 hours
* Pregnancy
* Contraindication to esophageal catheterization (e.g., esophageal varices)
* Conditions with increased risk of pneumothorax (such as severe COPD (Chronic Obstructive Pulmonary Disease) or extensive emphysema)
* Untreated pneumothorax
* Symptomatic airway obstruction

Discontinuation criteria during ongoing study intervention:

* Heart rate \> 120 beats/min
* Systolic blood pressure \> 180 mmHg
* Inspired oxygen fraction \> 70%
* Respiratory rate \> 35/min
* RASS (Richmond Agitation Sedation Scale) ≥ 2
* Doubling of norepinephrine dose or increase of norepinephrine dose to \> 0.5 µg/kg/min to maintain mean arterial pressure
* Bradycardia \< 45 beats/min

Where it's running

  • Central intensivvårdsavdelning, Sahlgrenska University Hospital
    Gothenburg, Västra Götaland County, Sweden
    Recruiting
  • Thorax intensivvårdsavdelning, Område 6, Sahlgrenska University Hospital, Västra Götalandsregionen
    Gothenburg, Västra Götaland County, Sweden
    Not yet recruiting

Study contacts

  • Principal investigator: Hannes Widing — Anesthesia and intensive care medicine, Område 5, Sahlgrenska University hospital, Västra Götalandsregionen
  • Study coordinator: Hannes Widing
  • Email: hannes.widing@vgregion.se
  • Phone: 0046703957374

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.